Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

15 May 2002

Prevalence of sleep disturbances in Chinese patients with end stage renal failureon maintenance hemodialysis.

Teresa Y H Wong, Thomas S T Li, Fanny W S Ko, David S C Hui, Dominic K L Choy, Cheuk C Szeto, Siu F Lui, Philip K T Li

Med Sci Monit 2002; 8(5): CR331-336 :: ID: 420840


BACKGROUND: Sleep disorders, such as daytime sleepiness, insomnia, restlesslegs syndrome (RLS) and obstructive sleep apnea syndrome (OSAS) have been reported as prevalent amongpatients with end stage renal failure(ESRF). MATERIAL/METHODS: As there is little published data fromSoutheast Asia, a sleep questionnaire was administered to all patients (N=43, 27 males) on chronic hemodialysis(HD) at the Prince of Wales Hospital, Hong Kong, to assess their sleep complaints. RESULTS: The meanage was 49.5 +/- 11.3 years (mean I SD) with mean body mass index (BMI) of 22.6 +/- 3.6 kg/m2. Frequentawakenings and sleep onset insomnia were the most frequent complaints (79% each), while daytime sleepinessoccurred in 74% of patients. Sleep maintenance insomnia and pruritus occurred in 64% and 60% of patientsrespectively. Symptoms of RLS were reported by 70% of patients. The prevalence of OSAS was estimatedby the frequency of observed choking (4.7% of cases), witnessed apnea (14%), snoring and witnessed apnea(9.3%), disruptive snoring (14%), disruptive snoring and witnessed apnea (2.3%), extremely loud snoring(4.7%). CONCLUSIONS: Our questionnaire survey revealed a high prevalence of sleep complaints such asfrequent awakenings, daytime sleepiness, insomnia and RLS in patients with ESRF on maintenance HD, buta relatively low prevalence of OSAS, which may be related to the low BMI of our ESRF patients.

Keywords: Body Mass Index, Kidney Failure, Renal Dialysis, Sleep Disorders, Snoring

Add Comment 0 Comments


01 May 2024 : Editorial  

Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)

Dinah V. Parums

DOI: 10.12659/MSM.944927

Med Sci Monit 2024; 30:e944927

In Press

Clinical Research  

Differential Inflammatory Responses in Adult and Pediatric COVID-19 Patients: Implications for Long-Term Co...

Med Sci Monit In Press; DOI: 10.12659/MSM.944052  

Clinical Research  

Effectiveness of Shoulder Taping in Treating Hemiplegic Shoulder Subluxation: A Randomized Controlled Study...

Med Sci Monit In Press; DOI: 10.12659/MSM.944222  

Clinical Research  

Comparison of Fentanyl, Ketamine, and Lidocaine Combined with Propofol Anesthesia in Patients with Crohn Di...

Med Sci Monit In Press; DOI: 10.12659/MSM.944116  

Database Analysis  

ANXA5: A Key Regulator of Immune Cell Infiltration in Hepatocellular Carcinoma

Med Sci Monit In Press; DOI: 10.12659/MSM.943523  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799


14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990


16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387


01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952


Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750